Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Oct. 13, 2020 NERV A 85,000 · · 85,000 Direct · Acquired (price as of 2026-10-05)
June 19, 2020 NERV A 153,531 · · 153,531 Direct · Acquired (price as of 2026-10-05)
Dec. 31, 2019 NERV A 41,469 · · 41,469 Direct · Acquired (price as of 2026-10-05)
Dec. 11, 2018 NERV A 120,000 · · 120,000 Direct · Acquired (price as of 2026-10-05)
Aug. 1, 2018 NERV A 200,000 · · 200,000 Direct · Acquired (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Oct. 13, 2020 NERV Employee Stock Option (right to buy) Common Stock (85,000) $3.50 Oct. 12, 2030 85,000 Acquired
June 19, 2020 NERV Employee Stock Option (right to buy) Common Stock (153,531) $7.11 Dec. 31, 2029 153,531 Acquired
Dec. 31, 2019 NERV Employee Stock Option (right to buy) Common Stock (41,469) $7.11 Dec. 30, 2029 41,469 Acquired
Dec. 11, 2018 NERV Employee Stock Option (right to buy) Common Stock (120,000) $7.96 Dec. 10, 2028 120,000 Acquired
Aug. 1, 2018 NERV Employee Stock Option (Righ to Buy) Common Stock (200,000) $7.95 Aug. 1, 2028 200,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).